Publikationen in Zusammenarbeit mit Forschern von Centro de Investigación Biomédica en Red sobre Enfermedades Hepáticas y Digestivas (21)

2024

  1. Evaluation of Genetic Variants Associated with the Risk of Thiopurine-Related Pancreatitis: A Case Control Study from ENEIDA Registry

    Digestive Diseases, Vol. 42, Núm. 3, pp. 257-264

2022

  1. Rawl's questionnaire spanish validation for colorectal cancer screening with faecal occult blood testing

    Gastroenterologia y Hepatologia, Vol. 45, Núm. 2, pp. 106-113

2021

  1. Gallbladder disease and pancreatic cancer risk: a multicentric case-control European study

    European journal of cancer prevention : the official journal of the European Cancer Prevention Organisation (ECP), Vol. 30, Núm. 6, pp. 423-430

2020

  1. Clinical significance of a microRNA signature for the identification and predicting prognosis in colorectal cancers with mucinous differentiation

    Carcinogenesis, Vol. 41, Núm. 11, pp. 1498-1506

  2. Does retraction after misconduct have an impact on citations? A pre-post study

    BMJ Global Health, Vol. 5, Núm. 11

  3. Multidisciplinary consensus statement on the clinical management of patients with pancreatic cancer

    Clinical and Translational Oncology, Vol. 22, Núm. 11, pp. 1963-1975

  4. Proceedings of the 25th annual congress of the international liver transplantation society

    Transplantation, Vol. 104, Núm. 8, pp. 1560-1565

  5. Spacing the Administration Interval of Anti-TNF Agents: A Valid Strategy for Patients with Inflammatory Bowel Disease?

    Digestive Diseases and Sciences, Vol. 65, Núm. 7, pp. 2036-2043

  6. Temporal Trends and Outcomes in Liver Transplantation for Recipients With HIV Infection in Europe and United States

    Transplantation, Vol. 104, Núm. 10, pp. 2078-2086

2018

  1. Direct-acting antivirals are effective and safe in HCV/HIV-coinfected liver transplant recipients who experience recurrence of hepatitis C: A prospective nationwide cohort study

    American Journal of Transplantation, Vol. 18, Núm. 10, pp. 2513-2522

2017

  1. Sofosbuvir and daclatasvir in mono-and HIV-coinfected patients with recurrent hepatitis C After liver transplant

    Annals of Hepatology, Vol. 16, Núm. 1, pp. 86-93

2016

  1. Epigenetic profiling to classify cancer of unknown primary: a multicentre, retrospective analysis

    The Lancet Oncology, Vol. 17, Núm. 10, pp. 1386-1395

  2. Erratum: Pegylated interferon plus ribavirin in HIV-infected patients with recurrent hepatitis C after liver transplantation: A prospective cohort study (Journal of Hepatology (2015) 62 (92-100))

    Journal of Hepatology

  3. Human immunodeficiency virus infection does not worsen prognosis of liver transplantation for hepatocellular carcinoma

    Hepatology, Vol. 63, Núm. 2, pp. 488-498

  4. Liver Retransplantation in Patients with HIV-1 Infection: An International Multicenter Cohort Study

    American Journal of Transplantation, Vol. 16, Núm. 2, pp. 679-687

  5. Treatment of severe recurrent hepatitis C after liver transplantation in HIV infected patients using sofosbuvir-based therapy

    Alimentary Pharmacology and Therapeutics, Vol. 43, Núm. 12, pp. 1319-1329

2015

  1. Acute cellular rejection versus recurrent hepatitis C after liver transplantation: Clinical and pathological features driving a rational diagnostic approach

    Hepatology Research, Vol. 45, Núm. 4, pp. 423-431

  2. Doubtful role of IL28B polymorphism in occult Hepatitis B infection

    Intervirology, Vol. 58, Núm. 3, pp. 160-165

  3. Pegylated interferon plus ribavirin in HIV-infected patients with recurrent hepatitis C after liver transplantation: A prospective cohort study

    Journal of Hepatology, Vol. 62, Núm. 1, pp. 92-100

2013

  1. Association of common genetic variants with risperidone adverse events in a Spanish schizophrenic population

    Pharmacogenomics Journal, Vol. 13, Núm. 2, pp. 197-204